Physician profile
Anthony Piccinone
NPI 1508915109
$4,257.97
in general payments reported to CMS, 2019-2025
38 companies · $714 in 2025
The $714 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $949 · 2022: $811 · 2023: $773 · 2024: $1,011 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,497.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $708.63 | 2021-2025 | |
| Novo Nordisk INC | $622.79 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $577.42 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Merck Sharp & Dohme LLC | $320.72 | 2021-2025 | Capvaxive, Gardasil 9, Gardasil |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $266.44 | 2022-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $202.21 | 2021-2024 | Zepbound, Mounjaro, Jardiance |
| Eisai INC. | $180.41 | 2021-2025 | |
| Pfizer INC. | $163.70 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.51 | 2022-2025 | |
| Exact Sciences Corporation | $123.85 | 2023-2024 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $111.96 | 2022-2023 | Quviviq |
| Braeburn INC. | $94.25 | 2024-2025 | Brixadi |
| Indivior INC. | $74.60 | 2021-2025 | Sublocade |
| Esperion Therapeutics, INC. | $56.63 | 2021-2023 | Nexletol |
| Sanofi Pasteur INC. | $54.64 | 2021-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Piccinone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.